These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7242315)

  • 21. Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
    Stephens JD; Marks C; Woodings D; Vandenburg MJ
    Cardiology; 1987; 74 Suppl 1():69-71. PubMed ID: 3607807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Left ventricular function parameters following administration of isosorbide-5-mononitrate].
    Bergbauer M
    Med Welt; 1983 Jun; 34(22):642-4. PubMed ID: 6877071
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of nitrosorbide on the hemodynamics under physical loading in patients with ischemic heart disease].
    Kupchinskaia EG; Stadniuk LA; Tkhor NV; Vysotskaia ZhM; Golub' NS
    Vrach Delo; 1986 Nov; (11):66-8. PubMed ID: 3825049
    [No Abstract]   [Full Text] [Related]  

  • 25. [Elantan in coronary heart disease. Report of experiences].
    Jahed M
    ZFA (Stuttgart); 1983 Aug; 59(22):1234-5. PubMed ID: 6624210
    [No Abstract]   [Full Text] [Related]  

  • 26. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency.
    Poliner LR; Ritter W; Wohl AJ; Nixon JV; Willerson JT
    Tex Med; 1977 Feb; 73(2):53-8. PubMed ID: 841487
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of isosorbide dinitrate on the blood circulation system in patients with ischemic heart disease].
    Gaponenko VA; Santova RA; Chilikina ON; Akhmetova MG; Moskalenko NP; Glezer GA
    Ross Med Zh; 1992; (4):45-7. PubMed ID: 1521022
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusion.
    Riva E; Kurosaki M; Latini R
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):490-5. PubMed ID: 1279297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].
    Jansen W; Osterspey A; Tauchert M; Schmid G; Schell U; Fuchs M; Hombach V; Hilger HH
    Dtsch Med Wochenschr; 1982 Oct; 107(40):1499-506. PubMed ID: 7117166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term therapy with nitrates. Relation between dosage and tolerance effect].
    Tauchert M; Jansen W; Metternich M; Osterspey A
    Herz; 1984 Jun; 9(3):153-65. PubMed ID: 6430769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose dependence of tolerance during treatment with mononitrates.
    Tauchert M; Jansen W; Osterspey A; Fuchs M; Hombach V; Hilger HH
    Z Kardiol; 1983; 72 Suppl 3():218-28. PubMed ID: 6666225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The duration of th effect of isosorbide-5-mononitrate--a new anti-anginal agent].
    Kozák P
    Vnitr Lek; 1985 Dec; 31(12):1217-21. PubMed ID: 4090311
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
    Caponnetto S; Canale C; Terrachini V; Masperone MA
    Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of nitroglycerin and isosorbiddinitrate on myocardial perfusion and hemodynamics in patients with and without coronary disease.
    Simon R; Amende I; Engel HJ; Lichtlen PR
    Scand J Clin Lab Invest Suppl; 1984; 173():47-58. PubMed ID: 6442002
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 39. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
    Müller G; Schmidt-Voigt J
    Med Welt; 1981 Apr; 32(14A):554-6. PubMed ID: 7242319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.